EnableComp Acquires Helix Advisory — Zero Balance Review Just Got a Lot Smarter
EnableComp just absorbed Helix Advisory, a Cincinnati-based recovery firm whose technology finds underpayments that rules-based audit systems are structurally designed to miss. For hospitals, the integration means zero balance review — previously a standalone vendor engagement or a manual process that didn't happen at all — now runs natively inside the same platform handling complex claims and denials.
What EnableComp Just Bought
EnableComp already processes roughly $3 billion in annual recoveries across more than 1,000 hospitals — complex claims, complex denials, and revenue recovery. Their gap was zero balance review: the set of claims that have already been paid, closed, and filed — but were paid wrong.
Helix Advisory's technology was built specifically for this. Three capabilities come with the acquisition:
- Underpayment detection beyond rules logic — finding discrepancies that predefined audit rules are structurally unable to flag
- Clinical signal detection — cross-referencing how a case was coded against what the payer actually reimbursed, surfacing mismatches that pure financial audit misses
- Root-cause analytics — tracing why an underpayment happened, not just that it happened, so clients can prevent future losses rather than only recovering past ones
Helix founder joins EnableComp leadership
Zack Higbie, Helix Advisory's founder, becomes VP of Revenue Recovery Products at EnableComp. The technology and the team transfer together — a signal this is an earnout-structured integration with real product continuity, not a pure acqui-hire.
Why Zero Balance Review Is the Overlooked Opportunity
Most hospital revenue cycle programs are built around active claims — things in queue, things in denial, things pending adjudication. Zero balance review is different. It covers claims the system already considers closed: the payer paid, the balance zeroed out, the case filed away.
The problem is that a significant portion of those payments are wrong — short-paid against the contracted rate, missing modifiers the payer should have applied, or underpaid relative to clinical documentation that wasn't surfaced at billing. The revenue is there. It just requires a different kind of audit to find it.
Conventional audit technology doesn't catch most of it because it's built on two assumptions that don't hold for this category:
- Rules-based logic — you can only find what you've told the system to look for. Helix's technology was built to find what nobody told it to look for.
- Claim size thresholds — most audit programs skip small-dollar claims because the manual review cost exceeds expected recovery. Automated detection removes that floor entirely.
Annual hospital underpayments from Medicare and Medicaid alone, per the American Hospital Association — before commercial payer underpayments are added. The majority goes unrecovered due to audit system limitations.
What This Means for EnableComp's Platform
Before this acquisition, a hospital working with EnableComp on complex claims and denials still needed a separate vendor relationship — or an internal team — to run zero balance review. That fragmentation has real costs: vendor management overhead, data silos, inconsistent methodology, and recovery programs that don't share intelligence across claim types.
Post-acquisition, EnableComp's pitch is a single platform that covers the full spectrum of hard-to-recover revenue: complex claims, complex denials, and now zero balance underpayments — all running on the same e360 RCM AI engine with shared clinical context.
"Most recovery programs are built to find what they're told to look for. Helix's technology finds what nobody told it to look for — that's the difference between a rules engine and real intelligence. Bringing that into EnableComp's platform means our clients stop leaving money on the table simply because a claim was too small or too complex for a standard audit to flag it."
— Frank Forte, CEO, EnableComp"Our early clients, large and small, are already seeing greater than 2% net revenue improvements on revenue that was previously unrecognized or written off."
— Zack Higbie, Founder, Helix Advisory / VP Revenue Recovery Products, EnableCompThe PE Angle
EnableComp is backed by Welsh, Carson, Anderson & Stowe — one of the most active healthcare PE firms in the country with 40+ years exclusively in healthcare and technology. WCAS-backed platforms tend to grow through acquisitions as much as organic product development. This deal fits that pattern cleanly: add a capability that expands TAM, accelerate integration, then use the combined platform to go upmarket or into new hospital segments.
EnableComp has now earned Black Book's #1 ranking in complex claims and revenue integrity for three consecutive years — 2024, 2025, and 2026. Helix's clinical intelligence bolsters the methodology behind that ranking heading into 2027 evaluations.
What RCM Teams Should Do With This
If you're an EnableComp client
Ask your rep directly: what's the integration timeline for Helix capabilities, and what does rollout look like for your account? The CEO said the unification work is "already underway" — get specific on what that means for your contract and your recovery program.
If you're running a standalone zero balance review program
This deal signals the direction of the market: ZBR is moving from a standalone specialty to a platform feature. If your current ZBR vendor is independent, start benchmarking their clinical signal detection against what EnableComp is now claiming. The 2% net revenue improvement number from Helix's early clients is the benchmark to pressure-test.
If you're evaluating complex RCM vendors
EnableComp now has a credible argument that it covers the most difficult revenue recovery problem set under one roof. That's a meaningful differentiator if your organization has historically managed three or four point solutions for complex claims, denials, and underpayment audit. Run the vendor consolidation math.
Bottom line
EnableComp just closed the zero balance gap in its platform. The combination of clinical signal detection, root-cause analytics, and scale across 1,000+ hospitals means underpayment recovery that previously required a separate vendor — or didn't happen at all — now runs inside one system. For hospitals leaving money in closed claims, this is the most significant ZBR development of 2026.
Related Coverage
- Waystar Deep Dive — How the platform-native RCM consolidation play is scaling.
- Ensemble Health Partners — Apollo-backed, $12B acquisition talks. The outsourced RCM consolidation thesis.
- XiFin + Notable Systems — Agentic document AI embedded in the intake layer.
Stay ahead of moves like this
M&A signals, payer shifts, and denial trends that hit your AR before you hear about them. Tuesday briefing, free.